This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Ludwig-Maximilians-Universitat München, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 50 
2 out of 1,334 
Years Active: 2018-2019
Title: **Paul Tavan: Innovator in Neurodegenerative Disease Research**
Introduction
Paul Tavan, an accomplished inventor based in Munich, Germany, has made significant contributions to the field of neurodegenerative diseases through his innovative research and patented inventions. With a total of two patents under his name, Tavan is dedicated to finding new solutions for critical health issues linked to protein aggregation.
Latest Patents
One of Paul Tavan's latest patents focuses on a drug designed to inhibit the aggregation of proteins involved in diseases associated with neurodegeneration. This invention relates to a compound represented by formula (E), which is aimed at treating or preventing diseases linked to protein aggregation. Additionally, Tavan's patent includes pharmaceutical and diagnostic compositions containing the compound, as well as a method for imaging deposits of aggregated proteins. A kit for preparing a detectably labelled version of this compound is also disclosed in his patent.
Career Highlights
Tavan's career has been marked by his association with prestigious institutions, including the Max Planck Society for the Advancement of Science and Ludwig Maximilian University of Munich. These affiliations have allowed him to collaborate with leading experts in his field and contribute to cutting-edge research in medicine.
Collaborations
Throughout his journey as an inventor, Paul Tavan has worked alongside notable colleagues, including Armin Giese and Uwe Bertsch. Their collaborative efforts have propelled advancements in understanding neurodegenerative diseases, helping to pave the way for innovative treatments.
Conclusion
Paul Tavan's dedication to advancing medical research is reflected in his groundbreaking patents and collaborations. His work not only highlights the importance of innovation in the treatment of neurodegenerative diseases but also emphasizes the collaborative nature of scientific progress. As research continues, Tavan’s inventions will play a crucial role in improving lives impacted by these debilitating conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile